FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ferroptosis, a cell death form linked to diseases, is detailed in the new FERREG database. This resource maps ferroptosis regulators, drugs, and disease links, aiding research and potential treatments.
Area Of Science
- Biochemistry and Molecular Biology
- Cell Biology
- Genetics
Background
- Ferroptosis is an iron-dependent cell death pathway implicated in diseases like cancer and neurodegeneration.
- Its regulation involves key pathways: system Xc-/GPX4 axis, lipid peroxidation, and iron metabolism.
- Understanding ferroptosis mechanisms is crucial for developing new therapeutic strategies.
Purpose Of The Study
- To introduce FERREG, a novel database for ferroptosis-related information.
- To consolidate data on ferroptosis regulation, disease association, and drug responses.
- To provide a comprehensive resource for researchers investigating ferroptosis.
Main Methods
- Systematic literature review and data mining.
- Integration of data from existing biological databases.
- Curation of information on ferroptosis targets, regulators, drugs, and disease associations.
Main Results
- The FERREG database contains 51 targets, 718 regulators, 445 drugs, and 158 disease responses related to ferroptosis.
- It explicitly describes molecular mechanisms and references data through cross-linking.
- FERREG provides a centralized platform for accessing ferroptosis-related knowledge.
Conclusions
- FERREG serves as a valuable, comprehensive resource for the ferroptosis research community.
- The database facilitates understanding of ferroptosis's role in disease and drug development.
- It supports the exploration of novel therapeutic interventions targeting ferroptosis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The cephalic phase is a conditioned or learned response to familiar foods. Our appetite or desire for a particular food modifies the preparatory responses directed by the brain. Individuals may produce more saliva and stomach...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...